PLX Protalix BioTherapeutics Inc.

$PLX Forget Elfabrio and Elelyso. If Protalix at this point was only a PRX-115 play, Gout, being 1 year away from it's trial data readout (knowing what the first trial data looked like), no debt and $40+MM in cash - would it not most likely be valued more than it is right now? Not making a joke here. There are small cap bios looking for their first drug approval in a smaller market than the Gout drug will be in and are valued much higher the PLX. PLX valuation is insanely low.

$PLX Brazil’s regulator, ANVISA, approved Elfabrio (pegunigalsidase alfa) for long-term enzyme-replacement therapy in adults with confirmed Fabry disease. The approval was announced on October 5, 2026, under Resolution RE No. 3,880/2026.

$PLX Increasing brokerage attention, Morgan Stanley, Stifel. Approaching full enrollment of Phase 2 trial in severe gout.

$PLX I just keep reminding myself that every week that goes by means more patients on Elfabrio and, ultimately, more revenue. It’s just a matter of time…

$PLX Dror Bashan my most favorite CEO ever, will be at my office 9am for a quick meeting/update… I’m a huge shareholder [standard stuff] 👨🏾‍🌾🥕🐈🐈‍⬛ *If you have any questions that cannot wait until a CC — please list them here; I will ask him directly & relay back

$PLX 🤣 doesn‘t go up with the market but also doesn‘t go down with market😂 pretty good hedge against rising interest rates.. :D

$PLX FDA label expansion will rally the stock higher and that BLA should be imminent as we get deeper into the 4th Qtr. Whose knows we could see another 5% holder pop up too. 3 at 5% is just the beginning:)!

$PLX New holder 13G HOLD Alapkezelo Zrt (Hungary) 4.157,791 shares. Any one knows who /what it is ?

$PLX Stifel presentation on November 10, very close to anticipated earnings date. I hope that's a good sign for earnings.

$PLX really a angle I never thought of was all the rich European funds that will start to buy in to PLX. One infusion per month will change many lives on many facets!

$PLX Above average volume today at 1.2M and up over 2%. Around 5 weeks likely until next earnings.

$PLX seems like we’ve been trading near a million shares a day… things looking up. Brazil, South Korea, Taiwan, Australia paying for Elfabrio. Soon most of Canada and France!

$PLX lmao after today’s news I reckon everyone realized that Israelis are absolutely badass and can do anything!! BUY ISRAEL STOCKS THESE GUYS ROCK!! 🤘🏼

$PLX Because of what was said at Morgan Stanley, there now seems to be a possibility of extending the once a month Elfabrio dosage option to the USA, where you not have the country by country approval delay present in Europe. As far as Europe goes, in less than five months it will be a full year since the decision, so the delay should be pretty much over by then. Plus we are approaching a major milestone, full enrollment of the RELEASE trial. And who knows, after nearly a year we may even hear something about Secarna.

$PLX Next huge catalyst is most likely higher royalty tier in 6 months! Besides 4 week dosing BLA filing in US! Plus 4 week dosing EU increasing revenues in EU and eating into Sanofi’s market share each month!

$PLX Rises above 2.80 - "Damn, why didn’t I buy more of this gem?" Drops below 2.70 - "Oh no… not again." It’s hard not to get emotional with this one. 😅

$PLX About 4 weeks until earnings. I'm curious if anyone has any interesting thoughts of what we might expect i.e. elfabrio numbers or anything else while we wait.

$PLX I never wanted to see this stock below $2.50 again. Too bad this stock doesn’t care what I want.

$PLX Nasty nasty looking tape today. Either somebody is trying to keep this under 2.50 (options?), somebody is happy to sell at 2.485 or somebody is diluting. The absurdly cheap price action continues.

$PLX $2.60 looks like major support and was tested several times lately! So far so good and Stronk 💪!